Business Context and Reporting Period
Microchip Technology Incorporated designs, manufactures and sells embedded control solutions, including mixed-signal microcontrollers, analog products, FPGAs, memory, connectivity and related technology licenses. The filing is a Form 10-K for the fiscal year ended March 31, 2024; it is not a quarterly filing for 2023 Q4. Fiscal 2024 results were affected by slowing economic activity, customer inventory reductions, higher interest rates, weaker demand in China and broader semiconductor-cycle normalization.
Microchip reported two segments: semiconductor products and technology licensing. Approximately 75% of fiscal 2024 sales were to foreign customers, with China representing approximately 18%, Taiwan 12% and Germany 10%. Distributors accounted for approximately 47% of sales, and Arrow Electronics accounted for 12%.
Financial Metrics
| Metric | Fiscal 2024 | Fiscal 2023 | Change |
|---|---|---|---|
| Net sales | $7,634.4 million | $8,438.7 million | Down 9.5% |
| Gross profit | $4,995.7 million | $5,697.9 million | Down 12.3% |
| Gross margin | 65.4% | 67.5% | Down 210 basis points |
| Operating income | $2,571.0 million | $3,116.0 million | Down 17.5% |
| Operating margin | 33.7% | 36.9% | Down 320 basis points |
| Net income | $1,906.9 million | $2,237.7 million | Down 14.8% |
| Diluted EPS | $3.48 | $4.02 | Down 13.4% |
| Cash flow from operations | $2,892.7 million | $3,621.0 million | Down 20.1% |
| Capital expenditures | $285.1 million | $486.2 million | Down 41.4% |
- Fiscal 2024 product-line sales were $4,272.4 million for mixed-signal microcontrollers, $2,016.4 million for analog products and $1,345.6 million for other products and services.
- Mixed-signal microcontroller sales declined approximately 10.2%; analog sales declined approximately 15.2%; other sales increased approximately 3.0%, primarily due to FPGA strength.
- Gross profit was reduced by inventory reserve impacts of $58.4 million, lower licensing revenue with no associated cost of sales, and $40.7 million of unabsorbed capacity charges resulting from operating below normal capacity.
- Research and development expense was $1,097.4 million, or 14.4% of sales, versus $1,118.3 million, or 13.3%, in fiscal 2023. Selling, general and administrative expense was $734.2 million, or 9.6% of sales, versus $797.7 million, or 9.5%.
- Cash and cash equivalents were $319.7 million at March 31, 2024, compared with $234.0 million at March 31, 2023. Inventory was $1,316.0 million, representing 224 days of inventory versus 169 days a year earlier.
- Total debt principal was $6,019.2 million, including $1,359.0 million of commercial paper, $750.0 million under the 2025 Term Loan Facility, $3,200.0 million of senior notes and $710.2 million of convertible debt. The company had no outstanding borrowings under its $2.75 billion revolving credit facility.
- Debt maturities based on contractual dates total $3,031.2 million in fiscal 2025, $1,950.0 million in fiscal 2026, $38.0 million in fiscal 2027 and $1,000.0 million in fiscal 2029.
- Fiscal 2024 financing uses included $911.5 million of dividends and approximately $982.1 million of share repurchases. Approximately $1.65 billion remained available under the $4.0 billion repurchase authorization.
Material Changes Versus the Prior Comparable Period
- Revenue declined 9.5% as customers reduced inventories, pushed out or cancelled orders, and demand weakened, particularly in China and Asia.
- Gross margin fell to 65.4% from 67.5%, reflecting unfavorable volume and mix, inventory reserves, lower licensing revenue and underutilized manufacturing capacity.
- Operating income and net income declined despite lower research and development, selling, general and administrative, and acquired-intangible amortization expenses.
- Operating cash flow decreased by $728.3 million, primarily because of lower net income and less favorable working-capital effects than in fiscal 2023.
- Capital expenditures were reduced substantially as Microchip paused most of its planned $800 million Fab 4 expansion and $880 million Fab 5 silicon carbide and silicon capacity expansion.
- Microchip discontinued its Preferred Supply Program for new orders in February 2024 as industry capacity conditions improved and product lead times declined. Existing long-term supply agreements were not affected.
- The company issued $1.0 billion of 5.050% senior notes due 2029, established a commercial paper program, and added a $750.0 million 2025 Term Loan Facility while retiring or settling several maturing debt instruments.
Guidance, Outlook, Commentary, Risks and Unusual Items
- Management reported improving bookings, fewer customer push-outs and cancellations, and increasing expedite and shipment pull-in requests beginning in the March 2024 quarter. However, the filing does not provide a clear quantitative fiscal 2025 revenue or earnings guidance figure.
- Microchip reduced production levels and implemented up to two weeks of shutdown days at global production facilities during the June 2024 quarter. Most factory expansion activity remained paused, and planned fiscal 2025 capital investment was reduced.
- The company expects to invest approximately $175 million in equipment and facilities over the next 12 months and expects to fund this spending with cash balances and operating cash flow.
- Management believes available liquidity, operating cash flow, the revolving credit facility, the term loan facility and commercial paper capacity will be sufficient for anticipated requirements for at least the next 12 months. This assessment depends on continued cash generation and access to refinancing markets.
- The $1.0 billion 0.983% notes mature on September 1, 2024. Management expects refinancing to occur through borrowings, commercial paper, or new senior notes or convertible debt, with potentially higher interest expense because market rates have increased.
- Microchip reached preliminary terms for $162 million of CHIPS Act grants, but final approval is subject to due diligence and negotiation. The filing provides no assurance that the grants will be received or on what timing or terms.
- Material tax contingencies include U.S. IRS transfer-pricing disputes and a Malaysian assessment that could result in taxes and penalties of up to $410.0 million if upheld. Gross unrecognized tax benefits were $792.4 million at March 31, 2024.
- Other risks include semiconductor cyclicality, excess inventory, dependence on outside wafer foundries, distributors and foreign operations, pricing pressure, manufacturing yields and capacity utilization, China and Taiwan geopolitical and trade risks, export controls, cybersecurity incidents, intellectual-property claims, environmental regulation and possible goodwill or intangible-asset impairment.
- As of March 31, 2024, the company had not identified a cybersecurity threat that materially affected its strategy, operations, results or financial condition. Management and the independent auditor concluded that internal control over financial reporting was effective.
- Special income and other, net was $12.3 million in fiscal 2024, primarily from favorable resolution of an unclaimed-property audit, partially offset by restructuring costs. No goodwill impairment was recorded.
Important Facts for Investors to Verify
- Verify the pace and durability of the reported improvement in bookings, pull-ins and customer order activity, particularly in China and other Asian markets.
- Monitor inventory days, distributor inventory of 41 days, customer push-outs, excess and obsolete inventory charges, and the effect of reduced production on gross margin.
- Confirm the refinancing and ultimate funding source for the $1.0 billion notes due September 2024 and assess the resulting interest expense and liquidity profile.
- Track total debt, commercial paper usage, credit ratings, covenant compliance and the ability to maintain dividends and share repurchases while funding capital expenditures.
- Assess whether the $162 million CHIPS Act grant receives final approval and whether Fab 4 and Fab 5 expansion plans resume.
- Review developments in the IRS and Malaysian tax disputes, including potential cash payments, interest and penalties.
- Evaluate dependence on external wafer foundries, foreign manufacturing, distributors and significant geographic markets, including China, Taiwan and Germany.
- Reconcile non-GAAP management commentary, if later provided, with the audited U.S. GAAP results summarized in this filing.